RSS   Newsletter   Contact   Advertise with us

Perrigo appoints Uwe Röhrhoff as CEO

Share on Twitter Share on LinkedIn
Staff Writer | Dublin, United Kingdom | January 9, 2018
Uwe RöhrhoffPerrigo Company, a provider of healthcare products, announced the appointment of Uwe Röhrhoff as chief executive officer, effective January 15, 2018.
Mr. Röhrhoff has more than 25 years of experience with Gerresheimer.

He began his career with Gerresheimer AG in 1991, steadily advancing within the organization to serve in a number of key leadership roles in Europe and North America.

Mr. Röhrhoff was appointed to build out the Company's business in the United States (1996-1998) and head the American subsidiary Gerresheimer Glass Inc. (2001-2010).

He served as an executive board member (2003-2017), responsible for two of the company's three business units, and CEO (2010-2017) of Gerresheimer AG until his retirement in August 2017.

Mr. Röhrhoff brings with him an extensive operational track record.

He led an organization that included 36 manufacturing facilities across 14 countries, delivering products to 1,500 customers, including the 10 largest global pharmaceutical companies, in nearly 100 countries.

Mr. Röhrhoff was instrumental in determining Gerresheimer AG's strategic focus, transforming and reshaping the corporate portfolio and delivering on operational projects.

Mr. Röhrhoff serves as Audit Committee Chairman on the Board of Directors of Catalent, Inc., a global provider of drug delivery technology and development solutions for drugs, biologics and consumer health products.

He is also Deputy Chairman of Klöckner&Co SE, one of the world's largest producer-independent steel and metal distributors.

Mr. Röhrhoff plans to step down from both boards.

Mr. Röhrhoff earned a business administration degree from the University of Cologne.

 LATEST MOVES FROM United Kingdom